Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

References

• Abe, K, Bridges, AS, Brouwer, KL. (2009). Use of sandwich-cultured human hepatocytes to predict biliary clearance of angiotensin II receptor blockers and HMG-CoA reductase inhibitors. Drug Metab Dispos 37:447–52
   PubMed Web of Science ®Google Scholar
• Abe, K, Bridges, AS, Yue, W, Brouwer, KL. (2008). In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance. J Pharmacol Exp Ther 326:983–90
   PubMed Web of Science ®Google Scholar
• Abu-Absi, SF, Friend, JR, Hansen, LK, Hu, WS. (2002). Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 274:56–67
   PubMed Web of Science ®Google Scholar
• Alexandre, E, Viollon-Abadie, C, David, P, et al. (2002). Cryopreservation of adult human hepatocytes obtained from resected liver biopsies. Cryobiology 44:103–13
   PubMed Web of Science ®Google Scholar
• Amenta, PS, Harrison, D. (1997). Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review. Microsc Res Tech 39:372–86
   PubMed Web of Science ®Google Scholar
• Annaert, PP, Brouwer, KL. (2005). Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metab Dispos 33:388–94
   PubMed Web of Science ®Google Scholar
• Annaert, PP, Turncliff, RZ, Booth, CL, et al. (2001). P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277–83
   PubMed Web of Science ®Google Scholar
• Anzai, N, Kanai, Y, Endou, H. (2006). Organic anion transporter family: current knowledge. J Pharmacol Sci 100:411–26
   PubMed Web of Science ®Google Scholar
• Aoki, K, Nakajima, M, Hoshi, Y, et al. (2008). Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. Biol Pharm Bull 31:412–20
   PubMed Web of Science ®Google Scholar
• Badolo, L, Trancart, MM, Gustavsson, L, Chesné, C. (2011). Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. Chem Biol Interact 190:165–70
   PubMed Web of Science ®Google Scholar
• Ballatori, N. (2004). Measurement of hepatobiliary transport. Curr Protoc Toxicol Chapter 14:Unit14.5
   PubMedGoogle Scholar
• Berry, MN, Grivell, AR, Grivell, MB, Phillips, JW. (1997). Isolated hepatocytes – past, present and future. Cell Biol Toxicol 13:223–33
   PubMed Web of Science ®Google Scholar
• Berthiaume, F, Moghe, PV, Toner, M, Yarmush, ML. (1996). Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J 10:1471–84
   PubMed Web of Science ®Google Scholar
• Bhatia, SN, Balis, UJ, Yarmush, ML, Toner, M. (1999). Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 13:1883–900
   PubMed Web of Science ®Google Scholar
• Bi, YA, Kazolias, D, Duignan, DB. (2006). Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Drug Metab Dispos 34:1658–65
   PubMed Web of Science ®Google Scholar
• Bi, YA, Kimoto, E, Sevidal, S, et al. (2012). In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation. Drug Metab Dispos 40:1085–92
   PubMed Web of Science ®Google Scholar
• Bleasby, K, Castle, JC, Roberts, CJ, et al. (2006). Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963–88
   PubMed Web of Science ®Google Scholar
• Bow, DA, Perry, JL, Miller, DS, et al. (2008). Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes. Drug Metab Dispos 36:198–202
   PubMed Web of Science ®Google Scholar
• Brandon, EF, Raap, CD, Meijerman, I, et al. (2003). An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233–46
   PubMed Web of Science ®Google Scholar
• Brown, HS, Griffin, M, Houston, JB. (2007). Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug Metab Dispos 35:293–301
   PubMed Web of Science ®Google Scholar
• Camenisch, G, Umehara, K. (2012). Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions. Biopharm Drug Dispos 33:179–94
   PubMed Web of Science ®Google Scholar
• Campion, SN, Johnson, R, Aleksunes, LM, et al. (2008). Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. Am J Physiol Gastrointest Liver Physiol 295:G294–304
   PubMed Web of Science ®Google Scholar
• Chan, LM, Lowes, S, Hirst, BH. (2004). The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:25–51
   PubMed Web of Science ®Google Scholar
• Chandra, P, Lecluyse, EL, Brouwer, KL. (2001). Optimization of culture conditions for determining hepatobiliary disposition of taurocholate in sandwich-cultured rat hepatocytes. In Vitro Cell Dev Biol Anim 37:380–5
   PubMed Web of Science ®Google Scholar
• Chandra, P, Zhang, P, Brouwer, KL. (2005). Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. Am J Physiol Gastrointest Liver Physiol 288:G1252–8
   PubMed Web of Science ®Google Scholar
• Cherrington, NJ, Slitt, AL, Li, N, Klaassen, CD. (2004). Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734–41
   PubMed Web of Science ®Google Scholar
• Ciarimboli, G. (2011). Role of organic cation transporters in drug-induced toxicity. Expert Opin Drug Metab Toxicol 7:159–74
   PubMed Web of Science ®Google Scholar
• Coleman, R, Wilton, JC, Stone, V, Chipman, JK. (1995). Hepatobiliary function and toxicity in vitro using isolated hepatocyte couplets. Gen Pharmacol 26:1445–53
   PubMedGoogle Scholar
• Courtois, A, Payen, L, Guillouzo, A, Fardel, O. (1999). Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett 459:381–5
   PubMed Web of Science ®Google Scholar
• Crocenzi, FA, Mottino, AD, Sánchez Pozzi, EJ, et al. (2003). Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat. Gut 52:1170–7
   PubMed Web of Science ®Google Scholar
• Dash, A, Inman, W, Hoffmaster, K, et al. (2009). Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 5:1159–74
   PubMed Web of Science ®Google Scholar
• De Bruyn, T, Fattah, S, Stieger, B, et al. (2011a). Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3. J Pharm Sci 100:5018–30
   PubMed Web of Science ®Google Scholar
• De Bruyn, T, Ye, ZW, Peeters, A, et al. (2011b). Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. Eur J Pharm Sci 43:297–307
   PubMed Web of Science ®Google Scholar
• De Kock, J, Ceelen, L, De Spiegelaere, W, et al. (2011). Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool? Arch Toxicol 85:607–12
   PubMed Web of Science ®Google Scholar
• Diao, L, Li, N, Brayman, TG, et al. (2010). Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}. J Biol Chem 285:31185–92
   PubMed Web of Science ®Google Scholar
• Dobson, PD, Kell, DB. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7:205–20
   PubMed Web of Science ®Google Scholar
• Donner, MG, Warskulat, U, Saha, N, Häussinger, D. (2004). Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385:331–9
   PubMed Web of Science ®Google Scholar
• Draheim, V, Reichel, A, Weitschies, W, Moenning, U. (2010). N-glycosylation of ABC transporters is associated with functional activity in sandwich-cultured rat hepatocytes. Eur J Pharm Sci 41:201–9
   PubMed Web of Science ®Google Scholar
• Faber, KN, Muller, M, Jansen, PLM. (2003). Drug transport proteins in the liver. Adv Drug Deliv Rev 55:107–24
   PubMed Web of Science ®Google Scholar
• Fardel, O, Le Vée, M. (2009). Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin Drug Metab Toxicol 5:1469–81
   PubMed Web of Science ®Google Scholar
• Fardel, O, Lecureur, V, Guillouzo, A. (1993). Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett 327:189–93
   PubMed Web of Science ®Google Scholar
• Fardel, O, Payen, L, Courtois, A, et al. (2001). Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology 167:37–46
   PubMed Web of Science ®Google Scholar
• Fattinger, K, Funk, C, Pantze, M, et al. (2001). The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69:223–31
   PubMed Web of Science ®Google Scholar
• Feng, B, Xu, JJ, Bi, YA, et al. (2009). Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714. Toxicol Sci 108:492–500
   PubMed Web of Science ®Google Scholar
• Fentem, JH, Foster, B, Mills, CO, et al. (1990). Biliary excretion of fluorescent cholephiles in hepatocyte couplets: an in vitro model for hepatobiliary and hepatotoxicity studies. Toxicol In Vitro 4:452–7
   PubMed Web of Science ®Google Scholar
• Fukuda, H, Ohashi, R, Ohashi, N, et al. (2010). Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats. Drug Metab Dispos 38:1505–13
   PubMed Web of Science ®Google Scholar
• Funk, C. (2008). The role of hepatic transporters in drug elimination. Expert Opin Drug Metab Toxicol 4:363–79
   PubMed Web of Science ®Google Scholar
• Funk, C, Ponelle, C, Scheuermann, G, Pantze, M. (2001). Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59:627–35
   PubMed Web of Science ®Google Scholar
• Gardiner, P, Paine, SW. (2011). The impact of hepatic uptake on the pharmacokinetics of organic anions. Drug Metab Dispos 39:1930–8
   PubMed Web of Science ®Google Scholar
• Giacomini, KM, Huang, SM, Tweedie, DJ, et al. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–36
   PubMed Web of Science ®Google Scholar
• Greer, ML, Barber, J, Eakins, J, Kenna, JG. (2010). Cell based approaches for evaluation of drug-induced liver injury. Toxicology 268:125–31
   PubMed Web of Science ®Google Scholar
• Gui, C, Miao, Y, Thompson, L, et al. (2008). Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur J Pharmacol 584:57–65
   PubMed Web of Science ®Google Scholar
• Guillouzo, A. (1998). Liver cell models in in vitro toxicology. Environ Health Perspect 106(Suppl 2):511–32
   Google Scholar
• Gómez-Lechón, MJ, Donato, MT, Castell, JV, Jover, R. (2003). Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4:292–312
   PubMed Web of Science ®Google Scholar
• Hagenbuch, B, Meier, PJ. (2004). Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653–65
   PubMed Web of Science ®Google Scholar
• Hagenbuch, N, Reichel, C, Stieger, B, et al. (2001). Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol 34:881–7
   PubMed Web of Science ®Google Scholar
• Hamilton, GA, Jolley, SL, Gilbert, D, et al. (2001). Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res 306:85–99
   PubMed Web of Science ®Google Scholar
• Hartman, JC, Brouwer, K, Mandagere, A, et al. (2010). Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol 88:682–91
   PubMed Web of Science ®Google Scholar
• Hasannejad, H, Takeda, M, Narikawa, S, et al. (2004). Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. Eur J Pharmacol 499:45–51
   PubMed Web of Science ®Google Scholar
• He, L, Vasiliou, K, Nebert, DW. (2009). Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics 3:195–206
   PubMedGoogle Scholar
• Hengstler, JG, Utesch, D, Steinberg, P, et al. (2000). Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81–118
   PubMed Web of Science ®Google Scholar
• Henkens, T, Papeleu, P, Elaut, G, et al. (2007). Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. Toxicol Appl Pharmacol 218:64–71
   PubMed Web of Science ®Google Scholar
• Hewitt, NJ, Lechón, MJ, Houston, JB, et al. (2007). Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234
   PubMed Web of Science ®Google Scholar
• Hilgendorf, C, Ahlin, G, Seithel, A, et al. (2007). Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333–40
   PubMed Web of Science ®Google Scholar
• Hirano, M, Maeda, K, Hayashi, H, et al. (2005). Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther 314:876–82
   PubMed Web of Science ®Google Scholar
• Hirano, M, Maeda, K, Shitara, Y, Sugiyama, Y. (2004). Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 311:139–46
   PubMed Web of Science ®Google Scholar
• Hirsch-Ernst, KI, Ziemann, C, Schmitz-Salue, C, et al. (1995). Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. Biochem Biophys Res Commun 215:179–85
   PubMed Web of Science ®Google Scholar
• Hoffmaster, KA, Turncliff, RZ, Lecluyse, EL, et al. (2004). P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharm Res 21:1294–302
   PubMed Web of Science ®Google Scholar
• Hoffmaster, KA, Zamek-Gliszczynski, MJ, Pollack, GM, Brouwer, KL. (2005). Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5]enkephalin. Drug Metab Dispos 33:287–93
   PubMed Web of Science ®Google Scholar
• Houle, R, Raoul, J, Lévesque, JF, et al. (2003). Retention of transporter activities in cryopreserved, isolated rat hepatocytes. Drug Metab Dispos 31:447–51
   PubMed Web of Science ®Google Scholar
• Iredale, JP, Arthur, MJ. (1994). Hepatocyte-matrix interactions. Gut 35:729–32
   PubMed Web of Science ®Google Scholar
• Ishiguro, N, Maeda, K, Kishimoto, W, et al. (2006). Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans. Drug Metab Dispos 34:1109–15
   PubMed Web of Science ®Google Scholar
• Ishizuka, H, Konno, K, Shiina, T, et al. (1999). Species differences in the transport activity for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 290:1324–30
   PubMed Web of Science ®Google Scholar
• Jacobsen, JK, Jensen, B, Skonberg, C, et al. (2011). Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes. Eur J Pharm Sci 44:427–36
   PubMed Web of Science ®Google Scholar
• Jemnitz, K, Veres, Z, Vereczkey, L. (2010). Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human. Toxicol Sci 115:80–8
   PubMed Web of Science ®Google Scholar
• Jigorel, E, Houston, JB. (2012). Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. Drug Metab Dispos 40:1596–602
   PubMed Web of Science ®Google Scholar
• Jigorel, E, Le Vee, M, Boursier-Neyret, C, et al. (2005). Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab Dispos 33:1418–22
   PubMed Web of Science ®Google Scholar
• Jigorel, E, Le Vee, M, Boursier-Neyret, C, et al. (2006). Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756–63
   PubMed Web of Science ®Google Scholar
• Jones, HM, Barton, HA, Lai, Y, et al. (2012). Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos 40:1007–17
   PubMed Web of Science ®Google Scholar
• Jørgensen, L, Van Beek, J, Lund, S, et al. (2007). Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes. Eur J Pharm Sci 30:181–9
   PubMed Web of Science ®Google Scholar
• Kato, Y, Suzuki, H, Sugiyama, Y. (2002). Toxicological implications of hepatobiliary transporters. Toxicology 181–182:287–90
   PubMed Web of Science ®Google Scholar
• Kell, DB, Dobson, PD, Oliver, SG. (2011). Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discov Today 16:704–14
   PubMed Web of Science ®Google Scholar
• Kemp, DC, Zamek-Gliszczynski, MJ, Brouwer, KL. (2005). Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes. Toxicol Sci 83:207–14
   PubMed Web of Science ®Google Scholar
• Kerr, ID, Haider, AJ, Gelissen, IC. (2011). The ABCG family of membrane-associated transporters: you don't have to be big to be mighty. Br J Pharmacol 164:1767–79
   PubMed Web of Science ®Google Scholar
• Kim, RB. (2002). Transporters and xenobiotic disposition. Toxicology 181–182:291–7
   PubMed Web of Science ®Google Scholar
• Kimoto, E, Chupka, J, Xiao, Y, et al. (2011). Characterization of digoxin uptake in sandwich-cultured human hepatocytes. Drug Metab Dispos 39:47–53
   PubMed Web of Science ®Google Scholar
• Kitamura, S, Maeda, K, Wang, Y, Sugiyama, Y. (2008). Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 36:2014–23
   PubMed Web of Science ®Google Scholar
• Klaassen, CD, Aleksunes, LM. (2010). Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1–96
   PubMed Web of Science ®Google Scholar
• Klein, K, Jüngst, C, Mwinyi, J, et al. (2010). The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1α (HNF-1α). Mol Pharmacol 78:1079–87
   PubMed Web of Science ®Google Scholar
• Koepsell, H, Endou, H. (2004). The SLC22 drug transporter family. Pflugers Arch 447:666–76
   PubMed Web of Science ®Google Scholar
• Kostrubsky, VE, Strom, SC, Hanson, J, et al. (2003). Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci 76:220–8
   PubMed Web of Science ®Google Scholar
• Kostrubsky, SE, Strom, SC, Kalgutkar, AS, et al. (2006). Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci 90:451–9
   PubMed Web of Science ®Google Scholar
• Kotani, N, Maeda, K, Watanabe, T, et al. (2011). Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes. Drug Metab Dispos 39:1503–10
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick, GA, Beuers, U, Paumgartner, G. (2000). Hepatobiliary transport. J Hepatol 32:3–18
   PubMed Web of Science ®Google Scholar
• Kusuhara, H, Sugiyama, Y. (2010). Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Drug Metab Rev 42:539–50
   PubMed Web of Science ®Google Scholar
• Lam, JL, Benet, LZ. (2004). Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Drug Metab Dispos 32:1311–16
   PubMed Web of Science ®Google Scholar
• Lam, JL, Okochi, H, Huang, Y, Benet, LZ. (2006). In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay. Drug Metab Dispos 34:1336–44
   PubMed Web of Science ®Google Scholar
• Lau, YY, Sapidou, E, Cui, X, et al. (2002). Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes. Drug Metab Dispos 30:1446–54
   PubMed Web of Science ®Google Scholar
• Le Vee, M, Gripon, P, Stieger, B, Fardel, O. (2008). Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 36:217–22
   PubMed Web of Science ®Google Scholar
• Le Vee, M, Lecureur, V, Moreau, A, Stieger, B, Fardel, O. (2009). Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes. Drug Metab Dispos 37:2228–35
   PubMed Web of Science ®Google Scholar
• Lecluyse, EL. (2001). Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13:343–68
   PubMed Web of Science ®Google Scholar
• Lecluyse, EL, Bullock, PL, Parkinson, A. (1996). Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatoytes. Adv Drug Deliv Rev 22:133–86
   Web of Science ®Google Scholar
• Lee, JK, Leslie, EM, Zamek-Gliszczynski, MJ, Brouwer, KL. (2008). Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity. Toxicol Appl Pharmacol 228:17–23
   PubMed Web of Science ®Google Scholar
• Lee, JK, Paine, MF, Brouwer, KL. (2010). Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes. J Pharmacol Exp Ther 334:410–18
   PubMed Web of Science ®Google Scholar
• Leslie, EM, Deeley, RG, Cole, SP. (2001). Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167:3–23
   PubMed Web of Science ®Google Scholar
• Leslie, EM, Watkins, PB, Kim, RB, Brouwer, KL. (2007). Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Ther 321:1170–8
   PubMed Web of Science ®Google Scholar
• Li, AP. (2008). Human hepatocytes as an effective alternative experimental system for the evaluation of human drug properties: general concepts and assay procedures. ALTEX 25:33–42
   PubMed Web of Science ®Google Scholar
• Li, AP, Lu, C, Brent, JA, et al. (1999). Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem Biol Interact 121:17–35
   PubMed Web of Science ®Google Scholar
• Li, M, Yuan, H, Li, N, et al. (2008). Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey, and human. Eur J Pharm Sci 35:114–26
   PubMed Web of Science ®Google Scholar
• Li, N, Bi, YA, Duignan, DB, Lai, Y. (2009a). Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes. Mol Pharm 6:1180–9
   PubMed Web of Science ®Google Scholar
• Li, N, Singh, P, Mandrell, KM, Lai, Y. (2010). Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm 7:630–41
   PubMed Web of Science ®Google Scholar
• Li, P, Wang, GJ, Robertson, TA, Roberts, MS. (2009b). Liver transporters in hepatic drug disposition: an update. Curr Drug Metab 10:482–98
   PubMed Web of Science ®Google Scholar
• Liang, D, Hagenbuch, B, Stieger, B, Meier, PJ. (1993). Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 18:1162–6
   PubMed Web of Science ®Google Scholar
• Liao, M, Raczynski, AR, Chen, M, et al. (2010). Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediated drug-drug interactions. Drug Metab Dispos 38:1612–22
   PubMed Web of Science ®Google Scholar
• Lickteig, AJ, Cheng, X, Augustine, LM, et al. (2008). Tissue distribution, ontogeny and induction of the transporters multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. Life Sci 83:59–64
   PubMed Web of Science ®Google Scholar
• Liu, L, Pang, KS. (2005). The roles of transporters and enzymes in hepatic drug processing. Drug Metab Dispos 33:1–9
   PubMed Web of Science ®Google Scholar
• Liu, X, Brouwer, KL, Gan, LS, et al. (1998). Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration. Pharm Res 15:1533–9
   PubMed Web of Science ®Google Scholar
• Liu, X, Chism, JP, Lecluyse, EL, et al. (1999a). Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637–44
   PubMed Web of Science ®Google Scholar
• Liu, X, Lecluyse, EL, Brouwer, KR, et al. (1999b). Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277:G12–21
   PubMed Web of Science ®Google Scholar
• Luckie, DB, Wilterding, JH, Krha, M, Krouse, ME. (2003). CFTR and MDR: aBC transporters with homologous structure but divergent function. Curr Genomics 4:109–21
   Google Scholar
• Luttringer, O, Theil, FP, Lavé, T, et al. (2002). Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. Biochem Pharmacol 64:1637–50
   PubMed Web of Science ®Google Scholar
• Madan, A, DeHaan, R, Mudra, D, et al. (1999). Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes. Drug Metab Dispos 27:327–35
   PubMed Web of Science ®Google Scholar
• Maeda, K, Kambara, M, Tian, Y, et al. (2006). Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8). Mol Pharm 3:70–7
   PubMedGoogle Scholar
• Maeda, T, Yotsumoto, T, Oyabu, M, Tamai, I. (2008). Effect of glucocorticoid receptor ligand dexamethasone on the expression of organic cation transporter in rat liver. Drug Metab Pharmacokinet 23:67–72
   PubMed Web of Science ®Google Scholar
• Maglova, LM, Jackson, AM, Meng, XJ, et al. (1995). Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets. Hepatology 22:637–47
   PubMed Web of Science ®Google Scholar
• Marion, TL, Leslie, EM, Brouwer, KL. (2007). Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity. Mol Pharm 4:911–18
   PubMed Web of Science ®Google Scholar
• May, JE, Xu, J, Morse, HR, et al. (2009). Toxicity testing: the search for an in vitro alternative to animal testing. Br J Biomed Sci 66:160–5
   PubMed Web of Science ®Google Scholar
• McRae, MP, Lowe, CM, Tian, X, et al. (2006). Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes. J Pharmacol Exp Ther 318:1068–75
   PubMed Web of Science ®Google Scholar
• Mills, CO, Milkiewicz, P, Müller, M, et al. (1999). Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR- rats. J Hepatol 31:678–84
   PubMed Web of Science ®Google Scholar
• Mita, S, Suzuki, H, Akita, H, et al. (2006). Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. Drug Metab Dispos 34:1575–81
   PubMed Web of Science ®Google Scholar
• Ménochet, K, Kenworthy, KE, Houston, JB, Galetin, A. (2012). Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model. J Pharmacol Exp Ther 341:2–15
   PubMed Web of Science ®Google Scholar
• Naiki, T, Nagaki, M, Asano, T, et al. (2005). Adenovirus-mediated hepatocyte nuclear factor-4alpha overexpression maintains liver phenotype in cultured rat hepatocytes. Biochem Biophys Res Commun 335:496–500
   PubMed Web of Science ®Google Scholar
• Nakagomi-Hagihara, R, Nakai, D, Tokui, T, et al. (2007). Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica 37:474–86
   PubMed Web of Science ®Google Scholar
• Nakakariya, M, Ono, M, Amano, N, et al. (2012). In vivo biliary clearance should be predicted by intrinsic biliary clearance in sandwich-cultured hepatocytes. Drug Metab Dispos 40:602–9
   PubMed Web of Science ®Google Scholar
• Nakakariya, M, Shimada, T, Irokawa, M, et al. (2008a). Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics. Pharm Res 25:578–85
   PubMed Web of Science ®Google Scholar
• Nakakariya, M, Shimada, T, Irokawa, M, et al. (2008b). Identification and species similarity of OATP transporters responsible for hepatic uptake of beta-lactam antibiotics. Drug Metab Pharmacokinet 23:347–55
   PubMed Web of Science ®Google Scholar
• Nakamura, T, Mura, T, Saito, K, et al. (1998). Adenovirus-transferred HNF-3 gamma conserves some liver functions in primary cultured hepatocytes of adult rats. Biochem Biophys Res Commun 253:352–7
   PubMed Web of Science ®Google Scholar
• Ni, Z, Bikadi, Z, Rosenberg, MF, Mao, Q. (2010). Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 11:603–17
   PubMed Web of Science ®Google Scholar
• Nishimura, M, Naito, S. (2005). Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20:452–77
   PubMedGoogle Scholar
• Noé, J, Portmann, R, Brun, ME, Funk, C. (2007). Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metab Dispos 35:1308–14
   PubMed Web of Science ®Google Scholar
• Ogimura, E, Sekine, S, Horie, T. (2011). Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem Biophys Res Commun 416:313–17
   PubMed Web of Science ®Google Scholar
• Olinga, P, Merema, M, Hof, IH, et al. (1998). Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data. J Pharmacol Exp Ther 285:506–10
   PubMed Web of Science ®Google Scholar
• Paine, AJ, Andreakos, E. (2004). Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitro. Toxicol In Vitro 18:187–93
   PubMed Web of Science ®Google Scholar
• Paine, SW, Parker, AJ, Gardiner, P, Webborn, PJ, Riley, RJ. (2008). Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Drug Metab Dispos 36:1365–74
   PubMed Web of Science ®Google Scholar
• Papeleu, P, Elaut, G, Rogiers, V, Vanhaecke, T. (2002). Cell cultures as in vitro models for biotransformation studies. In: Pandalia SG, ed. Recent research developments in drug metabolism and disposition. Kerala: india: Transworld Research Network
   Google Scholar
• Papeleu, P, Loyer, P, Vanhaecke, T, et al. (2003). Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. J Hepatol 39:374–82
   PubMed Web of Science ®Google Scholar
• Papeleu, P, Vanhaecke, T, Henkens, T, et al. (2006). Isolation of rat hepatocytes. Methods Mol Biol 320:229–37
   PubMedGoogle Scholar
• Parker, AJ, Houston, JB. (2008). Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir. Drug Metab Dispos 36:1375–84
   PubMed Web of Science ®Google Scholar
• Payen, L, Sparfel, L, Courtois, A, et al. (2002). The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol Toxicol 18:221–33
   PubMed Web of Science ®Google Scholar
• Poirier, A, Cascais, AC, Funk, C, Lavé, T. (2009a). Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn 36:585–611
   PubMed Web of Science ®Google Scholar
• Poirier, A, Funk, C, Scherrmann, JM, Lavé, T. (2009b). Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine. Mol Pharm 6:1716–33
   PubMed Web of Science ®Google Scholar
• Poirier, A, Lavé, T, Portmann, R, Brun, ME, et al. (2008). Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model. Drug Metab Dispos 36:2434–44
   PubMed Web of Science ®Google Scholar
• Reinoso, RF, Telfer, BA, Brennan, BS, Rowland, M. (2001). Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution. Drug Metab Dispos 29:453–9
   PubMed Web of Science ®Google Scholar
• Richert, L, Liguori, MJ, Abadie, C, et al. (2006). Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab Dispos 34:870–9
   PubMed Web of Science ®Google Scholar
• Rippin, SJ, Hagenbuch, B, Meier, PJ, Stieger, B. (2001). Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33:776–82
   PubMed Web of Science ®Google Scholar
• Rogiers, V, Vercruysse, A. (1998). Hepatocyte culturesin drug metabolism and toxicological research and testing. In: Philips, IR, Shepard, EA. (Eds.), Methods in molecular biology: ctyochrome P450 protocols. Clifton, New Jersey, USA: Humana
   Google Scholar
• Roma, MG, Orsler, DJ, Coleman, R. (1997). Canalicular retention as an in vitro assay of tight junctional permeability in isolated hepatocyte couplets: effects of protein kinase modulation and cholestatic agents. Fundam Appl Toxicol 37:71–81
   PubMedGoogle Scholar
• Roth, M, Obaidat, A, Hagenbuch, B. (2012). OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–87
   PubMed Web of Science ®Google Scholar
• Roymans, D, Annaert, P, Van Houdt, J, et al. (2005). Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes. Drug Metab Dispos 33:1004–16
   PubMed Web of Science ®Google Scholar
• Russel, FGM. (2010). Transporters: importance in drug absorption, distribution, and removal. In: Pang, KS, Rodrigues, AD, Peter, RM. (Eds.), Enzyme- and transporter-based drug-drug interactions: progress and future challenges, 1st ed. New York: Springer
   Google Scholar
• Sahi, J. (2005). Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates. Expert Opin Drug Metab Toxicol 1:409–27
   PubMedGoogle Scholar
• Schonhoff, CM, Gillin, H, Webster, CR, Anwer, MS. (2008). Protein kinase Cdelta mediates cyclic adenosine monophosphate-stimulated translocation of sodium taurocholate cotransporting polypeptide and multidrug resistant associated protein 2 in rat hepatocytes. Hepatology 47:1309–16
   Google Scholar
• Schuster, D, Laggner, C, Langer, T. (2005). Why drugs fail—a study on side effects in new chemical entities. Curr Pharmaceut Des 11:3545–59
   PubMed Web of Science ®Google Scholar
• Shimada, S, Fujino, H, Morikawa, T, et al. (2003). Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes. Drug Metab Pharmacokinet 18:245–51
   PubMedGoogle Scholar
• Shin, HJ, Anzai, N, Enomoto, A, et al. (2007). Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 45:1046–55
   PubMed Web of Science ®Google Scholar
• Shitara, Y, Hirano, M, Adachi, Y, et al. (2004). In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats. Drug Metab Dispos 32:1468–75
   PubMed Web of Science ®Google Scholar
• Shitara, Y, Itoh, T, Sato, H, et al. (2003a). Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther 304:610–16
   PubMed Web of Science ®Google Scholar
• Shitara, Y, Li, AP, Kato, Y, et al. (2003b). Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 18:33–41
   PubMedGoogle Scholar
• Shugarts, S, Benet, LZ. (2009). The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 26:2039–54
   PubMed Web of Science ®Google Scholar
• Sidhu, JS, Liu, F, Omiecinski, CJ. (2004). Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 292:252–64
   PubMed Web of Science ®Google Scholar
• Silva, JM, Day, SH, Nicoll-Griffith, DA. (1999). Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem Biol Interact 121:49–63
   PubMed Web of Science ®Google Scholar
• Sivaraman, A, Leach, JK, Townsend, S, et al. (2005). A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6:569–91
   PubMed Web of Science ®Google Scholar
• Soars, MG, Grime, K, Sproston, JL, et al. (2007a). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859–65
   PubMed Web of Science ®Google Scholar
• Soars, MG, McGinnity, DF, Grime, K, Riley, RJ. (2007b). The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 168:2–15
   PubMed Web of Science ®Google Scholar
• Soars, MG, Webborn, PJ, Riley, RJ. (2009). Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol Pharm 6:1662–77
   PubMed Web of Science ®Google Scholar
• Sun, H, Huang, Y, Frassetto, L, Benet, LZ. (2004). Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. Drug Metab Dispos 32:1239–46
   PubMed Web of Science ®Google Scholar
• Swift, B, Pfeifer, ND, Brouwer, KL. (2010). Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446–71
   PubMed Web of Science ®Google Scholar
• Szakács, G, Váradi, A, Ozvegy-Laczka, C, Sarkadi, B. (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13:379–93
   PubMed Web of Science ®Google Scholar
• Tanino, T, Nawa, A, Nakao, M, et al. (2009). Organic anion transporting polypeptide 2-mediated uptake of paclitaxel and 2’-ethylcarbonate-linked paclitaxel in freshly isolated rat hepatocytes. J Pharm Pharmacol 61:1029–35
   PubMed Web of Science ®Google Scholar
• Tchaparian, EH, Houghton, JS, Uyeda, C, et al. (2011). Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes. Drug Metab Dispos 39:2387–94
   PubMed Web of Science ®Google Scholar
• Thompson, TN. (2011). The clinical significance of drug transporters in drug disposition and drug interactions. In: Bonate PL, Howard DR, eds. Pharmacokinetics in drug development. New York: Springer
   Google Scholar
• Tian, X, Zamek-Gliszczynski, MJ, Zhang, P, Brouwer, KL. (2004). Modulation of multidrug resistance-associated protein 2 (Mrp2) and Mrp3 expression and function with small interfering RNA in sandwich-cultured rat hepatocytes. Mol Pharmacol 66:1004–10
   PubMed Web of Science ®Google Scholar
• Treiber, A, Schneiter, R, Häusler, S, Stieger, B. (2007). Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos 35:1400–7
   PubMed Web of Science ®Google Scholar
• Treijtel, N, van Eijkeren, JC, Nijmeijer, S, et al. (2009). Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes. Toxicol In Vitro 23:185–93
   PubMed Web of Science ®Google Scholar
• Tsuda-Tsukimoto, M, Maeda, T, Iwanaga, T, et al. (2006). Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035. Pharm Res 23:2646–56
   PubMed Web of Science ®Google Scholar
• Turncliff, RZ, Meier, PJ, Brouwer, KL. (2004). Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metab Dispos 32:834–9
   PubMed Web of Science ®Google Scholar
• Turncliff, RZ, Tian, X, Brouwer, KL. (2006). Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochem Pharmacol 71:1520–9
   PubMed Web of Science ®Google Scholar
• Tuschl, G, Hrach, J, Walter, Y, et al. (2009). Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies. Chem Biol Interact 181:124–37
   PubMed Web of Science ®Google Scholar
• Tuschl, G, Mueller, SO. (2006). Effects of cell culture conditions on primary rat hepatocytes-cell morphology and differential gene expression. Toxicology 218:205–15
   PubMed Web of Science ®Google Scholar
• Ueda, K, Kato, Y, Komatsu, K, Sugiyama, Y. (2001). Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. J Pharmacol Exp Ther 297:1036–43
   PubMed Web of Science ®Google Scholar
• Ullrich, A, Stolz, DB, Ellis, EC, et al. (2009). Long term cultures of primary human hepatocytes as an alternative to drug testing in animals. ALTEX 26:295–302
   PubMed Web of Science ®Google Scholar
• Ulvestad, M, Björquist, P, Molden, E, et al. (2011). OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. Biochem Pharmacol 82:1219–26
   PubMed Web of Science ®Google Scholar
• Umehara, K, Camenisch, G. (2012). Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 29:603–17
   PubMed Web of Science ®Google Scholar
• Umehara, KI, Iwatsubo, T, Noguchi, K, Kamimura, H. (2007). Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats. Xenobiotica 37:818–31
   PubMed Web of Science ®Google Scholar
• Vanhaecke, T, Papeleu, P, Elaut, G, Rogiers, V. (2004). Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem 11:1629–43
   PubMed Web of Science ®Google Scholar
• Varma, MV, Lai, Y, Feng, B, et al. (2012). Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. Pharm Res 29:2860–73
   PubMed Web of Science ®Google Scholar
• Vee, ML, Lecureur, V, Stieger, B, Fardel, O. (2009). Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37:685–93
   PubMed Web of Science ®Google Scholar
• Vinken, M, Elaut, G, Henkens, T, et al. (2006a). Rat hepatocyte cultures: collagen gel sandwich and immobilization cultures. Methods Mol Biol 320:247–54
   PubMedGoogle Scholar
• Vinken, M, Henkens, T, Vanhaecke, T, et al. (2006b). Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. Toxicol Sci 91:484–92
   PubMed Web of Science ®Google Scholar
• Wagner, M, Trauner, M. (2005). Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol 4:77–99
   PubMedGoogle Scholar
• Warskulat, U, Kubitz, R, Wettstein, M, et al. (1999). Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes. Biol Chem 380:1273–9
   PubMed Web of Science ®Google Scholar
• Watanabe, T, Kusuhara, H, Maeda, K, et al. (2010). Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab Dispos 38:215–22
   PubMed Web of Science ®Google Scholar
• Watanabe, T, Kusuhara, H, Maeda, K, et al. (2009). Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 328:652–62
   PubMed Web of Science ®Google Scholar
• Webster, CR, Blanch, C, Anwer, MS. (2002). Role of PP2B in cAMP-induced dephosphorylation and translocation of NTCP. Am J Physiol Gastrointest Liver Physiol 283:G44–50
   PubMed Web of Science ®Google Scholar
• Wolf, KK, Vora, S, Webster, LO, et al. (2010). Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport. Toxicol In Vitro 24:297–309
   PubMed Web of Science ®Google Scholar
• Yabe, Y, Galetin, A, Houston, JB. (2011). Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808–14
   PubMed Web of Science ®Google Scholar
• Yamada, A, Maeda, K, Kamiyama, E, et al. (2007). Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos 35:2166–76
   PubMed Web of Science ®Google Scholar
• Yamashiro, W, Maeda, K, Hirouchi, M, et al. (2006). Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Drug Metab Dispos 34:1247–54
   PubMed Web of Science ®Google Scholar
• Yanni, SB, Augustijns, PF, Benjamin, DK, et al. (2010). In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats. Drug Metab Dispos 38:1848–56
   PubMed Web of Science ®Google Scholar
• Ye, ZW, Augustijns, P, Annaert, P. (2008). Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors. Drug Metab Dispos 36:1315–21
   PubMed Web of Science ®Google Scholar
• Ye, ZW, Van Pelt, J, Camus, S, et al. (2010). Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes. J Pharm Sci 99:2886–98
   PubMed Web of Science ®Google Scholar
• You, G. (2004). The role of organic ion transporters in drug disposition: an update. Curr Drug Metab 5:55–62
   PubMed Web of Science ®Google Scholar
• Yu, AM. (2007). Small interfering RNA in drug metabolism and transport. Curr Drug Metab 8:700–8
   PubMed Web of Science ®Google Scholar
• Yue, W, Lee, JK, Abe, K, et al. (2011). Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR−) rats. Drug Metab Dispos 39:441–7
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski, MJ, Xiong, H, Patel, NJ, et al. (2003). Pharmacokinetics of 5 (and 6)-carboxy-2’,7’-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801–9
   PubMed Web of Science ®Google Scholar
• Zeilinger, K, Sauer, IM, Pless, G, et al. (2002). Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions. Altern Lab Anim 30:525–38
   PubMed Web of Science ®Google Scholar
• Zhang, L, Strong, JM, Qiu, W, et al. (2006). Scientific perspectives on drug transporters and their role in drug interactions. Mol Pharm 3:62–9
   PubMed Web of Science ®Google Scholar
• Zhang, P, Tian, X, Chandra, P, Brouwer, KL. (2005). Role of glycosylation in trafficking of Mrp2 in sandwich-cultured rat hepatocytes. Mol Pharmacol 67:1334–41
   PubMed Web of Science ®Google Scholar
• Zucchetti, AE, Barosso, IR, Boaglio, A, et al. (2011). Prevention of estradiol 17beta-D-glucuronide-induced canalicular transporter internalization by hormonal modulation of cAMP in rat hepatocytes. Mol Biol Cell 22:3902–15
   PubMed Web of Science ®Google Scholar